Click here to create your personal news page. The news that appears on Eli Lilly will appear there and be constantly updated. You can then modify the page, share it with your friends, or export it and have it appear elsewhere.

You can also create a personal news page and follow the news that interests you by clicking on the tab labelled 'New page'.
 

topics : related - allExplore

Wikio Shopping

  1. 1. Computers
  2. 2. Electronics
  3. 3. Communication
  4. 4. Household Appliances
  5. 5. Car/Motor Bike
  6. 6. Digital Camera
  7. 7. Mobile Phone
  8. 8. Smartphone
  9. 9. PDA
  10. 10. GPS
  11. 11. LCD Monitor
  12. 12. Printer

New products

  1. 1. Canon Pixma iP4600
  2. 2. Navigon PNA 7200T
  3. 3. Genius MP-300
  4. 4. ViewSonic VX2265wm
  5. 5. Sony TA-DA5400ES
  6. 6. XFX GeForce 9800 GTX+ XXX
  7. 7. GeForce 9400 GT
  8. go to Shopping

Participate



Eli Lilly


Sort by : relevance - date - popularity
+Vote!

Eli Lilly's Depression Drug May Cut Chronic Low Back Pain

Eli Lilly and Co.'s Cymbalta depression treatment significantly reduced back pain in comparison with a placebo, new studies suggest. The drug is prescribed to treat depression, generalized anxiety disorder, diabetic nerve pain, and fibromyalgia. The pharmaceutical company carried out a study on 236 adults with chronic low back pain who weren't depressed. They took Cymbalta or a placebo drug daily for...

+Vote!

Eli Lilly Cracks Me Up

So first they come out with a drug that causes diabetes, then covered it up, and they're in a hell of a lot of trouble because of it. And now, guess what? A drug that Lily makes to treat diabetes...

+Vote!

Movers: Amylin, Eli Lilly, Dollar Tree, J.Crew, Borders, Talbots

Movers: Amylin, Eli Lilly, Dollar Tree, J.Crew, Borders, TalbotsStocks in the news Wednesday Amylin Pharmaceuticals () and Eli Lilly's () diabetes drug Byetta reportedly was linked to four more deaths in patients with pancreatitis, adding to two deaths announced by federal regulators last week. Baird reportedly downgrades to neutral from outperform. Cowen maintains neutral. Dollar Tree () posts $0.42,...

+Vote!

Eli Lilly’s (LLY) Gift To The Funeral Industry

The National Funeral Directors Association must be sending “thank you” cards to Eli Lilly (LLY) and it partner Amylin (AMLN). Together, the companies developed... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

+Vote!

Eli Lilly, Amylin report 4 new pancreatitis deaths in patients who took diabetes drug Byetta

WASHINGTON (AP) _ Eli Lilly and Amylin Pharmaceuticals Inc. on Tuesday reported four new deaths in patients taking Byetta, even as the companies tried to ...

+Vote!

Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA

SAN DIEGO and INDIANAPOLIS, Aug. 26 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: ) and Eli Lilly and Company (NYSE: ) in a conference call today provided context and additional information regarding the August 18, 2008 U.S. Food and Drug Administration (FDA) update to a prior alert for BYETTA(R) (exenatide) injection referencing pancreatitis. The companies were aware of the pancreatitis...

+Vote!

Research and Markets: An Analysis of Eli Lilly, One of the Top 10 World's Leading Pharmaceutical Companies: Including a Financial Analysis, and Overview of Major Trends

DUBLIN, Ireland - (Business Wire) Research and Markets () has announced the addition of the "The Top 10 World's Leading Pharmaceutical Companies: Eli Lilly" report to their offering. In a highly dynamic and fragmented pharmaceutical market, besieged by intense competition, rapid pace of technological innovations and the uncertainty regarding future government regulations, the ability to anticipate...

+Vote!

Research and Markets: An Analysis of Eli Lilly, One of the Top 10 World's Leading Pharmaceutical Companies: Including a Financial Analysis, and Overview of Major Trends

The study provides an approximately 50-page worldwide strategic overview of the pharmaceutical market, including sales forecast for major product segments (ethical, OTC, generics); key geographic regions (North America, Western Europe, Japan, Eastern Europe, and Latin America); major drug categories, including cardiovascular, gastrointestinal, antibiotics, CNS, respiratory, musculoskeletal, hormonal/genitourinary,...

+Vote!

Two More Deaths Reported From Diabetes Drug Byetta Bringing Total To 6

The makers of the type 2 diabetes drug Byetta reported Tuesday the deaths of four more people who'd been taking the medication bringing the total to six. Last week, Eli Lilly & Co. and Amylin Pharmaceuticals Inc.'s diabetes drug Byetta was linked to two deaths and four hospitalizations. All the patients are reported to have died after developing acute pancreatitis, the manufacturer said. The condition...

+Vote!

Diabetes Drug Tied to New Deaths

The New York Times reports that four more deaths may be linked to the diabetes drug Byetta. The New York Times writes, The diabetes drug Byetta, marketed by Eli Lilly & Company and Amylin Pharmaceuticals, was linked to four more...

+Vote!

Rough Road Ahead For Byetta

Amylin and Eli Lilly will have to calm investors' fears over its risky diabetes drug.

+Vote!

Amylin Woes Continue

Shares of Amlyin Pharmaceuticals have been hit hard Wednesday, falling 26% after the company, along with its partner Eli Lilly, announced that four patients who took the company’s diabetes drug, Byetta, had died of pancreatitis. This follows a similar report of two deaths from the FDA last week. Several analysts have [...]

+Vote!

4 More Deaths Reported Among Byetta Patients

August 26 — The makers of the type 2 diabetes drug Byetta reported Tuesday the deaths of four more people who’d been taking the medication. The announcement by Eli Lilly and Amylin Pharmaceuticals Inc. came a week after the U.S. Food and Drug Administration said that two Byetta users had died of acute pancreatitis, a [...]

+Vote!

Baneful Byetta

Four new deaths stemmed from Amylin and Eli Lilly's diabetes drug, which sent investors running.

+Vote!

Bad News Byetta

Amylin Pharmaceuticals and Eli Lilly announce four new deaths among patients taking the diabetes drug.